Masayuki Hosoi

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Kohjiro Ueki, Takayoshi Sasako, Yukiko Okazaki et al. · The Lancet Diabetes & Endocrinology · 2017 · 309 citations

Medicine, Cardiology, Internal Medicine +13

β-Glycerophosphate Accelerates Calcification in Cultured Bovine Vascular Smooth Muscle Cells

Atsushi Shioi, Yoshiki Nishizawà, Shuichi Jono et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1995 · 292 citations · Full text

Life Sciences, Biochemistry, Cell Biology +11

Protein Kinase C δ Inhibits the Proliferation of Vascular Smooth Muscle Cells by Suppressing G1 Cyclin Expression

Shinya Fukumoto, Yoshiki Nishizawà, Masayuki Hosoi et al. · Journal of Biological Chemistry · 1997 · 166 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Intrarenal hemodynamic abnormalities in diabetic nephropathy measured by duplex Doppler sonography

Eiji Ishimura, Yoshiki Nishizawà, Takahiko Kawagishi et al. · Kidney International · 1997 · 145 citations · Full text

Medicine, Endocrinology, Nephrology +14

Peroxisome Proliferator-Activated Receptor-γ Agonists Increase Vascular Endothelial Growth Factor Expression in Human Vascular Smooth Muscle Cells

Kenjiro Yamakawa, Masayuki Hosoi, Hidenori Koyama et al. · Biochemical and Biophysical Research Communications · 2000 · 136 citations

Life Sciences, Pharmacology, Cell Signaling +6